Discontinuation of oral antivirals in chronic hepatitis B: A systematic review-Reference-Cited by-同舟云学术

Discontinuation of oral antivirals in chronic hepatitis B: A systematic review

Published:2016-03-04 Issue:5 Volume:63 Page:1481-1492
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Papatheodoridis George¹,Vlachogiannakos Ioannis¹,Cholongitas Evangelos²,Wursthorn Karsten³,Thomadakis Christos⁴,Touloumi Giota⁴,Petersen Jörg³

Affiliation:

1. Academic Department of Gastroenterology; Medical School of National and Kapodistrian University of Athens, Laiko General Hospital of Athens; Athens Greece

2. 4th Department of Internal Medicine; Medical School of Aristotle University, Hippokration General Hospital of Thessaloniki; Thessaloniki Greece

3. IFI Institute at Asklepios Klinik St. Georg; University of Hamburg; Hamburg Germany

4. Department of Hygiene, Epidemiology, and Medical Statistics; Medical School of National and Kapodistrian University of Athens; Athens Greece

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.28438/fullpdf

Reference41 articles.

1. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection;European Association for the Study of the Liver;J Hepatol,2012

2. Chronic hepatitis B: update 2009;Lok;Hepatology,2009

3. Therapeutic strategies in the management of patients with chronic hepatitis B;Papatheodoridis;Lancet Infect Dis,2008

4. Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?;Papatheodoridis;Liver Int,2013

5. Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B;Chang;Hepatology,2010

Cited by 232 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of hepatitis B virus relapse in cancer patients receiving chemotherapy with prophylactic nucleos(t)ide analogues: Implications for overall mortality;Liver International;2024-07-10

2. Long-term hepatitis B surface antigen kinetics after nucleos(t)ide analog discontinuation in patients with noncirrhotic chronic hepatitis B;Liver Research;2024-07

3. Discontinuation of Nucleos(t)ide Analogues in HBeAg Negative Chronic Hepatitis B Patients: Risks and Benefits;Infectious Diseases and Clinical Microbiology;2024-06-28

4. Stopping Nucleos(t)ide Analogues in Chronic Hepatitis B Using HBsAg Thresholds: A Meta-Analysis and Meta-Regression;Clinical Gastroenterology and Hepatology;2024-06

5. Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study);American Journal of Gastroenterology;2024-05-14